Mechanism of Action of Abiraterone Acetate 7 | Download Scientific Diagram
Oncology
AUA 2012 - mCRPC in focus: Androgen biosynthesis inhibition and metastatic castration-resistant prostate cancer, clinical insights from the Clinical Industry Theater presentation by Judd Moul, MD
Abiraterone Acetate - an overview | ScienceDirect Topics
Abiraterone: New Drug in the Treatment of Metastatic Castration-resistant Prostate Cancer - The ASCO Post
Cancers | Free Full-Text | The Prostate Cancer Therapy Enzalutamide Compared with Abiraterone Acetate/Prednisone Impacts Motivation for Exploration, Spatial Learning and Alters Dopaminergic Transmission in Aged Castrated Mice
Abiraterone | Uses, Brand Names, Mechanism Of Action
pipeline -
CYP17 blockade by abiraterone: further evidence for frequent continued hormone-dependence in castration-resistant prostate cancer | British Journal of Cancer
Abiraterone acetate in the treatment of prostate cancer - ScienceDirect
202379Orig1s000
Abiraterone acetate in the treatment of prostate cancer - ScienceDirect
Abiraterone acetate: A novel drug for castration-resistant prostate carcinoma Nandha R - J Postgrad Med
2011 Prostate Cancer Highlights, Prostate Cancer Research Program, Congressionally Directed Medical Research Programs
Resistance to second generation antiandrogens in prostate cancer: pathways and mechanisms
Abiraterone Acetate tablets 250mg price in India
Abiraterone and other novel androgen-directed strategies for the treatment of prostate cancer: a new era of hormonal therapies is born - Michael T. Schweizer, Emmanuel S. Antonarakis, 2012
Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302) final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 ...
Optimal sequencing of enzalutamide and abiraterone acetate plus prednisone in metastatic castration-resistant prostate cancer: a multicentre, randomised, open-label, phase 2, crossover trial - The Lancet Oncology
Cancers | Free Full-Text | Eighty Years of Targeting Androgen Receptor Activity in Prostate Cancer: The Fight Goes on
How ZYTIGA® Works | ZYTIGA® (abiraterone acetate)
TSPYL Family Regulates CYP17A1 and CYP3A4 Expression: Potential Mechanism Contributing to Abiraterone Response in Metastatic Castration‐Resistant Prostate Cancer - Qin - 2018 - Clinical Pharmacology & Therapeutics - Wiley Online Library
Heart failure and atrial tachyarrhythmia on abiraterone: A pharmacovigilance study - ScienceDirect
Enzalutamide versus abiraterone as a first-line endocrine therapy for castration-resistant prostate cancer (ENABLE study for PCa): a study protocol for a multicenter randomized phase III trial | BMC Cancer | Full Text
